Precision radiation boost tested to fight tough esophageal cancer
NCT ID NCT07359443
Summary
This early-stage trial is testing whether adding a more precise form of radiation (MR-guided radiotherapy) to standard chemotherapy before surgery can better control esophageal cancer. The study aims to find the safest and most effective radiation dose for 39 patients with a specific type of esophageal cancer (adenocarcinoma). Researchers hope this combination will reduce the chance of the cancer returning, especially by preventing it from spreading to other parts of the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Center Utrecht
RECRUITINGUtrecht, Utrecht, 3582CX, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.